Terms of service.
Last updated: 2026-05-27 · Effective: 2026-05-27
These Terms of Service ("Terms") form a binding agreement between Oushvaa Technologies ("Oushvaa," "we," "us," "our") and you, the user ("you," "your"). They govern your access to and use of the MedevIQ product, including medeviq.ai, the authenticated workspace, the MedevIQ API, transactional email and notification delivery, and any related services (together, the "Service"). By accessing or using the Service, you agree to these Terms. If you are accessing the Service on behalf of an organization, you represent that you have authority to bind that organization, and "you" refers to both you and that organization.
If you do not agree to these Terms, do not access or use the Service.
1. The Service
MedevIQ is a medical-device reference layer. It reconciles and synthesizes information from publicly documented medical-device regulators (India CDSCO MD&IVD, US FDA UDI Database, EU EUDAMED, Health Canada MDALL, TGA ARTG, PMDA, MHRA Public Access Database, NMPA, Swissmedic, ANVISA, and others), the GMDN classification, recognized clinical-investigation registries (ClinicalTrials.gov, EU CTIS, CTRI), authoritative device-coding sources (UDI, EMDN, SNOMED CT device subset), adverse- event databases (MAUDE, MHRA Yellow Card devices), and adjacent healthcare data (collectively, the "Source Records"). MedevIQ returns answers traced to citations identifying the underlying Source Records.
2. Eligibility and accounts
2.1 Eligibility
The Service is intended for use by professionals in the pharmaceutical, biotechnology, regulatory, clinical, pharmacy, and adjacent healthcare sectors. By using the Service, you represent that you are at least 18 years of age and have legal capacity to enter into these Terms.
2.2 Access provisioning
The Service is currently available by invitation. Access is granted at our discretion after you submit a Request Access form and we provision your account. We may decline, suspend, or revoke access for any lawful reason, including breach of these Terms.
2.3 Account credentials
You are responsible for maintaining the confidentiality of any credentials, sign-in tokens, API keys, or other authentication material associated with your account. You are responsible for all activity undertaken through your account. Notify us promptly at [email protected] of any actual or suspected unauthorized access.
3. Acceptable use
You will not, and will not permit any third party to, use the Service to:
- Scrape, redistribute, resell, or otherwise commercially exploit the Service's outputs, the synthesis layer, or any non-public data accessed through the Service, except as expressly permitted by your access agreement.
- Build, train, or improve any competing product, aggregation service, or generative AI model using outputs from or interactions with the Service.
- Bypass, disable, or interfere with rate limits, authentication, access controls, or any security or technical-protection measures.
- Submit queries or upload content for the purpose of probing model weaknesses, jailbreaking, or extracting confidential prompts or system instructions.
- Upload content containing malware, viruses, or other harmful code.
- Upload content that infringes the intellectual property, privacy, or other rights of any third party.
- Use the Service in any manner that violates applicable law, including the DPDP Act, the IT Act, the Drugs and Cosmetics Act, the Medical Devices Rules 2017, or applicable foreign laws.
- Use the Service to generate or distribute content intended to mislead consumers about a drug's safety, efficacy, or regulatory status.
Because the Service proxies certain queries to upstream APIs (notably the Anthropic API), abusive query volumes, query patterns designed to bypass safety filters, or activity that puts our upstream relationships at risk may be throttled, suspended, or terminated. We may, but are not obligated to, monitor usage for compliance.
4. Reference, not advice
MedevIQ is a reference and synthesis layer. The Service's outputs are informational. Nothing on or accessible through the Service constitutes:
- Medical advice, diagnosis, treatment, or prescribing recommendation;
- Regulatory advice or a regulatory opinion;
- Legal advice or legal opinion;
- Investment, financial, or trading advice;
- A representation or warranty as to the current regulatory status of any drug, except where the Source Record is identified and cited.
See the disclaimer for the full scope of this provision. You remain solely responsible for any decision you make based on outputs from the Service and must independently verify any output before relying on it for any regulated activity.
5. Customer data and outputs
5.1 Your data
As between you and us, you own the questions you submit, the documents you upload, and any personal data contained therein for which you are the Data Fiduciary. We process your data only as described in our Privacy Policy and our Data Processing Agreement.
5.2 Outputs
Subject to your compliance with these Terms, we grant you a worldwide, non-exclusive, non-transferable, royalty-free right to use the outputs the Service generates in response to your queries for your internal business purposes. You may not redistribute outputs as a substitute service for MedevIQ. Citations and provenance metadata accompanying outputs must not be stripped or obscured when outputs are shared with your colleagues, contractors, or customers internally.
5.3 Aggregated and anonymized data
We may collect aggregated and anonymized statistics about Service usage (query volumes, latency distributions, error rates, feature adoption) that do not identify you or any Data Principal. We may use such aggregated and anonymized data to operate, improve, and benchmark the Service. We will not use your query content or uploaded documents to train any AI model without your explicit opt-in consent.
6. Intellectual property
The Service, including its software, query catalogue, pipeline architecture, citation engine, synthesis logic, user interface, brand marks, and documentation, is the property of Oushvaa or its licensors and is protected by intellectual property laws in India and other jurisdictions. Nothing in these Terms grants you any right, title, or interest in the Service except the limited rights of access and use expressly granted here.
Source Records remain in their original copyright posture as determined by their respective regulators, registries, or rights-holders. MedevIQ's value is the synthesis, citation, and presentation work performed over those records, not the underlying facts. Where Source Records are published under open government data policies (for example, US FDA OpenFDA, India CDSCO public notices), we adhere to the terms of those policies.
You retain ownership of any feedback you submit to us. By submitting feedback, you grant us a perpetual, worldwide, royalty-free, sublicensable license to use that feedback to operate and improve the Service.
7. Fees and payment
The Service is currently in private preview without a published price. Pricing for general availability will be announced separately and reflected in your individual access agreement. Where fees apply, they are payable in advance per the schedule in that agreement. Taxes (GST or equivalent) are additional unless explicitly stated otherwise.
Late payments may incur interest at the lesser of 1.5% per month or the maximum rate permitted by law, and may result in suspension of the Service until cured.
8. Term and termination
8.1 Term
These Terms apply from your first access to the Service and continue until your account is terminated per this Section.
8.2 Termination by you
You may terminate by ceasing to use the Service and sending written notice to [email protected]. Termination does not entitle you to a refund of pre-paid fees except where required by applicable law or stated in your access agreement.
8.3 Termination by us
We may suspend or terminate your access (a) on 30 days' written notice for any reason; (b) immediately for material breach of these Terms that you fail to cure within 10 days of written notice; or (c) immediately and without notice if we reasonably determine that your use poses a security risk, violates law, or exposes us, our sub-processors, or other users to material liability.
8.4 Effect of termination
Upon termination, your right to access the Service ceases. We will retain or delete your data as described in our Privacy Policy and the DPA. Provisions that by their nature survive termination (including IP, confidentiality, disclaimers, limitations of liability, indemnities, and dispute resolution) will survive.
9. Confidentiality
Each party will protect the other's Confidential Information using at least the same care it uses to protect its own (and no less than a reasonable standard of care). "Confidential Information" means non-public information disclosed by one party to the other that is identified as confidential or that a reasonable person would understand to be confidential, including the Service's pricing, architecture, and roadmap, and your account credentials and uploaded content.
10. Warranties and disclaimers
We warrant that we will provide the Service with reasonable skill and care, in accordance with applicable law, and in substantial conformity with our published documentation as it exists from time to time.
Except as expressly stated in the preceding paragraph, the Service is provided "as is" and "as available" without warranty of any kind. To the maximum extent permitted by law, we disclaim all other warranties, whether express, implied, statutory, or otherwise, including implied warranties of merchantability, fitness for a particular purpose, non-infringement, title, accuracy, completeness, and uninterrupted operation. We do not warrant that the Service will be error-free, that defects will be corrected, or that outputs are suitable for any particular use case without independent verification.
11. Limitation of liability
To the maximum extent permitted by law:
- Neither party will be liable for any indirect, incidental, special, consequential, exemplary, or punitive damages, including loss of profits, revenue, business, data, or goodwill, arising out of or relating to these Terms or the Service, even if advised of the possibility of such damages.
- Our aggregate liability arising out of or relating to these Terms and the Service, regardless of the form of action, is limited to the greater of (a) the fees paid by you to us for the Service in the 12 months preceding the event giving rise to the claim, or (b) INR 50,000.
The limitations in this Section do not apply to (i) your obligation to pay fees due; (ii) either party's indemnification obligations; (iii) breach of confidentiality; (iv) infringement of the other party's intellectual property; or (v) liabilities that cannot be excluded under applicable law (including liability for fraud, gross negligence, or wilful misconduct).
12. Indemnification
12.1 By us
We will defend you against any third-party claim alleging that the Service, as provided by us and used by you in accordance with these Terms, infringes a registered intellectual property right of that third party in India, and will pay the damages and reasonable legal fees finally awarded against you in settlement of, or in a final judgment on, such a claim. Our obligation does not extend to claims arising from (a) your use of the Service in combination with non-Oushvaa products or services; (b) modifications to the Service not made by us; (c) Source Records and the underlying rights-holders' assertions; or (d) your breach of these Terms.
12.2 By you
You will defend us against any third-party claim arising out of (a) your breach of these Terms or applicable law; (b) content you upload that infringes the rights of a third party; or (c) your use of outputs from the Service in a manner that exceeds the licenses granted here, and will pay the damages and reasonable legal fees finally awarded against us in settlement of, or in a final judgment on, such a claim.
13. Force majeure
Neither party is liable for any failure or delay in performance (other than payment obligations) to the extent caused by events beyond its reasonable control, including acts of God, natural disasters, war, terrorism, riots, civil disturbances, fire, epidemic or pandemic measures, governmental orders, outages of internet backbone or major cloud providers, or labor disputes.
14. Modifications to these Terms
We may revise these Terms from time to time. We will post the revised Terms on this page with an updated effective date. Material changes will be communicated to active users by email or in-product notice at least 30 days before they take effect. Your continued use of the Service after the effective date constitutes acceptance of the revised Terms. If you do not accept the revised Terms, you must stop using the Service before the effective date.
15. Governing law and dispute resolution
These Terms are governed by the laws of India, without regard to conflict-of-laws principles. Subject to the dispute-resolution mechanism below, the courts at Ernakulam, Kerala, India have exclusive jurisdiction over any dispute arising out of or relating to these Terms or the Service. Where your access agreement specifies a different forum, that forum will apply between you and us.
15.1 Pre-dispute consultation
Before initiating any legal action, the parties will attempt in good faith to resolve any dispute through written notice and consultation for a period of at least 30 days.
15.2 Arbitration (Enterprise only)
Where specified in an Enterprise access agreement, disputes will be referred to arbitration under the Arbitration and Conciliation Act, 1996 (as amended), before a sole arbitrator mutually agreed by the parties (or, failing agreement, appointed by the relevant arbitral institution). The seat of arbitration will be Ernakulam, Kerala, India. The language will be English.
16. Notices
Notices to us must be sent in writing to [email protected] and are effective upon our acknowledgment of receipt. Notices to you may be sent to the email address associated with your account and are effective when sent. You are responsible for keeping that email address current.
17. General
These Terms, together with your access agreement, our Privacy Policy, the DPA, and any other document incorporated by reference, are the entire agreement between the parties relating to the Service and supersede all prior or contemporaneous communications. No provision may be waived except by a written instrument signed by the waiving party. If any provision is held unenforceable, the remaining provisions remain in full force and effect. Neither party may assign these Terms without the other's prior written consent, except that we may assign without consent in connection with a merger, acquisition, or sale of substantially all our assets. These Terms are binding upon and inure to the benefit of the parties and their permitted successors and assigns. There are no third-party beneficiaries.
18. Contact
Questions about these Terms: [email protected]
Security or abuse reports: [email protected]
General support: [email protected]